Steris Offers Device Rebates To Settle FDA Claims

Law360, New York (April 20, 2010, 1:59 PM EDT) -- Facing threats from the U.S. Food and Drug Administration, Steris Corp. said Tuesday that it would offer up to $100 million worth of rebates to customers who bought one of the company's surgical instrument sterilization devices that the agency maintains lacks regulatory approval.

The rebate program comes as part of a consent decree, which requires approval from the U.S. District Court for the Northern District of Ohio, resolving the FDA's claims that the company continued to sell its System 1 liquid chemical sterilization system despite warnings...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.